Considering the positive correlation between HLX expression and PD-1, CTLA4, PDL-1, and LAG3 expressions in CRC patients, HLX might play a role in regulating immune checkpoints and influencing the response to immunotherapy. This evidence concerns the gene HLX and colorectal carcinoma.